Identifying Barriers and Disparities in the Healthcare of Patients with Alopecia Areata: A Mixed-Methods Analysis Using Claims Data and Qualitative Interview Data

This study examines the healthcare challenges faced by patients with alopecia areata (AA) in Germany, revealing significant barriers and disparities. Using a mixed-methods approach, it combines qualitative interviews with 20 patients and 14 dermatologists and claims data analysis of 4,692 individuals. The findings show that AA treatments are often not reimbursed due to their classification as a 'lifestyle disease,' limiting access to effective medications like JAK inhibitors. Only 57.5% of patients received drug prescriptions, primarily from general practitioners and dermatologists, with urban patients and women more likely to receive treatment. The study highlights the need for reclassifying AA as an autoimmune disease to improve reimbursement and care, and recommends creating an information platform for patients and physicians to address these disparities. Additionally, it emphasizes the importance of mental health support and patient involvement in treatment decisions.